The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
4-{[4-[[[N'-[[5-Fluoro-2-hydroxy-3-(2-propenyl)phenyl]-methylene]hydrazine]carbonyl]methyl]-1-piperazinyl]methyl}-benzensulfonamide ID: ALA3426428
Chembl Id: CHEMBL3426428
PubChem CID: 136934935
Max Phase: Preclinical
Molecular Formula: C23H28FN5O4S
Molecular Weight: 489.57
Molecule Type: Small molecule
Associated Items:
Names and Identifiers Canonical SMILES: C=CCc1cc(F)cc(/C=N/NC(=O)CN2CCN(Cc3ccc(S(N)(=O)=O)cc3)CC2)c1O
Standard InChI: InChI=1S/C23H28FN5O4S/c1-2-3-18-12-20(24)13-19(23(18)31)14-26-27-22(30)16-29-10-8-28(9-11-29)15-17-4-6-21(7-5-17)34(25,32)33/h2,4-7,12-14,31H,1,3,8-11,15-16H2,(H,27,30)(H2,25,32,33)/b26-14+
Standard InChI Key: HZVPIBIKJJAVIB-VULFUBBASA-N
Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 489.57Molecular Weight (Monoisotopic): 489.1846AlogP: 1.18#Rotatable Bonds: 9Polar Surface Area: 128.33Molecular Species: NEUTRALHBA: 7HBD: 3#RO5 Violations: 0HBA (Lipinski): 9HBD (Lipinski): 4#RO5 Violations (Lipinski): 0CX Acidic pKa: 8.30CX Basic pKa: 6.16CX LogP: 2.12CX LogD: 2.04Aromatic Rings: 2Heavy Atoms: 34QED Weighted: 0.28Np Likeness Score: -1.71
References 1. Roth HS, Botham RC, Schmid SC, Fan TM, Dirikolu L, Hergenrother PJ.. (2015) Removal of Metabolic Liabilities Enables Development of Derivatives of Procaspase-Activating Compound 1 (PAC-1) with Improved Pharmacokinetics., 58 (9): [PMID:25856364 ] [10.1021/acs.jmedchem.5b00413 ]